Kala Visvanathan
- Cancer Research top 1%
- Breast Cancer Treatment Studies 20
- Cancer, Lipids, and Metabolism 18
- Cancer Genomics and Diagnostics 13
- Oncology top 1%
- Cancer Risks and Factors 43
- Global Cancer Incidence and Screening 20
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 18
- Obstetrics and Gynecology top 2%
- Physiology top 2%
-
- Estrogen and related hormone effects 25
- BRCA gene mutations in cancer 21
- Co-authors
- Patricia HartgeLinda SharpThomas I. BarronAmy Berrington de GonzálezMartha S. LinetAlpa V. PatelCharles E. MatthewsElisabete Weiderpass
- Journals
- Cancer Epidemiology Biomarkers & Prevention (20 papers)Journal of Clinical Oncology (20 papers)Cancer Research (10 papers)
- Partner nations
- United StatesFinlandIreland
In The Last Decade
Kala Visvanathan
179 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Cancer Research 1.7k
- Oncology 2.2k
- Reproductive Medicine 648
- Obstetrics and Gynecology 345
- Physiology 1.1k
Countries citing papers authored by Kala Visvanathan
This map shows the geographic impact of Kala Visvanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kala Visvanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kala Visvanathan more than expected).
Fields of papers citing papers by Kala Visvanathan
This network shows the impact of papers produced by Kala Visvanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kala Visvanathan. The network helps show where Kala Visvanathan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kala Visvanathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 11 | |
| 12 | 2020 | 21 | |
| 13 | 2020 | 85 | |
| 14 | 2019 | 117 | |
| 15 | 2018 | 49 | |
| 16 | 2015 | 39 | |
| 17 | 2015 | 21 | |
| 18 | 2015 | 49 | |
| 19 | 2014 | 118 | |
| 20 | 2011 | 428 |
About Kala Visvanathan
Kala Visvanathan is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Obstetrics and Gynecology and Genetics, having authored 191 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer Risks and Factors (43 papers), Estrogen and related hormone effects (25 papers), BRCA gene mutations in cancer (21 papers), Global Cancer Incidence and Screening (20 papers), Breast Cancer Treatment Studies (20 papers), Ovarian cancer diagnosis and treatment (18 papers), Cancer, Lipids, and Metabolism (18 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.2k citations), Reproductive Medicine (648 citations), Obstetrics and Gynecology (345 citations) and Physiology (1.1k citations). Kala Visvanathan has collaborated with scholars based in United States, Finland and Ireland. Frequent co-authors include Patricia Hartge, Linda Sharp, Thomas I. Barron, Amy Berrington de González, Martha S. Linet, Alpa V. Patel, Charles E. Matthews, Elisabete Weiderpass, Steven C. Moore and Kathleen Bennett. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment and Cancer Causes & Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.